FDA is preparing to have a private, independent consulting firm assess its management of the device pre-market review process. On Dec. 19, the agency issued a statement of work plan for the assessment and opened a 30-day comment period to obtain industry feedback.
It was the device industry that originally called for the assessment, gaining FDA's promise to take the step during negotiations over this year's user fee reauthorization. The assessment will be...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?